Fulgent Genetics Inc (FLGT)
20.32
+0.19
(+0.94%)
USD |
NASDAQ |
Apr 19, 16:00
20.32
0.00 (0.00%)
After-Hours: 19:38
Fulgent Genetics Revenue (Annual): 289.21M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 289.21M |
| December 31, 2022 | 618.97M |
| December 31, 2021 | 992.58M |
| December 31, 2020 | 421.71M |
| December 31, 2019 | 32.53M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.35M |
| December 31, 2017 | 18.73M |
| December 31, 2016 | 18.28M |
| December 31, 2015 | 9.576M |
| December 31, 2014 | 1.278M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
32.53M
Minimum
2019
992.58M
Maximum
2021
471.00M
Average
421.71M
Median
2020
Revenue (Annual) Benchmarks
| Delcath Systems Inc | 2.065M |
| Star Equity Holdings Inc | 45.78M |
| Exact Sciences Corp | 2.500B |
| CytoSorbents Corp | 31.08M |
| Progyny Inc | 1.089B |